Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
Cardiovascular Reserve Evaluation in Survivors of Transplantation (CREST)
Sponsor: City of Hope Medical Center
Listed as NCT04537871, this observational or N/A phase trial focuses on Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia and remains ongoing. Sponsored by City of Hope Medical Center, it has been updated 13 times since 2020, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
13 versions recorded-
Oct 2025 — Present [monthly]
Active Not Recruiting
-
Feb 2025 — Oct 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Nov 2023 — Jun 2024 [monthly]
Recruiting
-
Apr 2023 — Nov 2023 [monthly]
Recruiting
-
Apr 2022 — Apr 2023 [monthly]
Recruiting
-
Dec 2021 — Apr 2022 [monthly]
Recruiting
-
Mar 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- City of Hope Medical Center
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .